학술논문

A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
Document Type
Article
Source
In Blood Advances 26 March 2024 8(6):1384-1391
Subject
Transplantation
Immunobiology and Immunotherapy
Lymphoid Neoplasia
Clinical Trials and Observations
Language
ISSN
2473-9529